Literature DB >> 15310463

Role of alphavbeta5 integrins and vitronectin in Pseudomonas aeruginosa PAK interaction with A549 respiratory cells.

Johanne Leroy-Dudal1, Hélène Gagnière, Elisabeth Cossard, Franck Carreiras, Patrick Di Martino.   

Abstract

Bacterial adherence to mammalian cells and their internalization are thought to participate in Pseudomonas aeruginosa pathogenicity. In this study, we explored the role of alpha5beta1 and alphavbeta5 integrins and their natural ligands, fibronectin (Fn) and vitronectin (Vn), in P. aeruginosa interaction with epithelial cells by using the PAK reference bacterial strain, A549 respiratory, and SKOV-3 human ovarian cell lines. The host cell cytoskeleton and cellular tyrosine kinases seem to be solicited during the PAK-respiratory cell interaction: cytochalasin D and genistein decreased the bacterial adherence and internalization. Blocking antibodies to alphavbeta5 integrins were the only antibodies tested to have inhibitory activity against PAK adherence to A549 cells. PAK internalization by A549 and SKOV-3 cells was markedly decreased in the presence of blocking antibodies to Vn and alphavbeta5 integrins. Addition of Vn in excess restored PAK invasion of both A549 and SKOV-3 cells in the presence of anti-Vn antibodies. Immunofluorescence experiments revealed that, in the presence of bacteria, the Vn fibrillar network disappeared, and alphavbeta5 staining was concentrated in sites where adherent bacteria were present. Taken together, these findings suggest that alphavbeta5 integrins, and their natural ligand Vn, are involved in PAK entry into human epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310463     DOI: 10.1016/j.micinf.2004.05.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  13 in total

1.  Identification of outer membrane Porin D as a vitronectin-binding factor in cystic fibrosis clinical isolates of Pseudomonas aeruginosa.

Authors:  Magnus Paulsson; Birendra Singh; Tamim Al-Jubair; Yu-Ching Su; Niels Høiby; Kristian Riesbeck
Journal:  J Cyst Fibros       Date:  2015-06-03       Impact factor: 5.482

Review 2.  Microbial uptake by the respiratory epithelium: outcomes for host and pathogen.

Authors:  Margherita Bertuzzi; Gemma E Hayes; Elaine M Bignell
Journal:  FEMS Microbiol Rev       Date:  2019-03-01       Impact factor: 16.408

3.  A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells.

Authors:  Birendra Singh; Yu-Ching Su; Tamim Al-Jubair; Oindrilla Mukherjee; Teresia Hallström; Matthias Mörgelin; Anna M Blom; Kristian Riesbeck
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

4.  Pseudomonas aeruginosa PilY1 binds integrin in an RGD- and calcium-dependent manner.

Authors:  Michael D L Johnson; Christopher K Garrett; Jennifer E Bond; Kimberly A Coggan; Matthew C Wolfgang; Matthew R Redinbo
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

5.  Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells.

Authors:  Gregory B Pott; K Scott Beard; Courtney L Bryan; Daniel T Merrick; Leland Shapiro
Journal:  Front Public Health       Date:  2013-06-21

6.  The Rickettsia conorii Adr1 Interacts with the C-Terminus of Human Vitronectin in a Salt-Sensitive Manner.

Authors:  Abigail I Fish; Sean P Riley; Birendra Singh; Kristian Riesbeck; Juan J Martinez
Journal:  Front Cell Infect Microbiol       Date:  2017-03-01       Impact factor: 5.293

Review 7.  The role of epithelial integrin receptors in recognition of pulmonary pathogens.

Authors:  Marina Ulanova; Sean Gravelle; Rebecca Barnes
Journal:  J Innate Immun       Date:  2008-06-25       Impact factor: 7.349

8.  Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.

Authors:  Teresia Hallström; Melanie Uhde; Birendra Singh; Christine Skerka; Kristian Riesbeck; Peter F Zipfel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

9.  Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.

Authors:  Teresia Hallström; Birendra Singh; Peter Kraiczy; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel; Kristian Riesbeck
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  The Pseudomonas aeruginosa Lectin LecB Causes Integrin Internalization and Inhibits Epithelial Wound Healing.

Authors:  Roland Thuenauer; Alessia Landi; Anne Trefzer; Silke Altmann; Sarah Wehrum; Thorsten Eierhoff; Britta Diedrich; Jörn Dengjel; Alexander Nyström; Anne Imberty; Winfried Römer
Journal:  mBio       Date:  2020-03-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.